Latest filing published 16 Aug 2021 for Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.), €60k.
All filings by David Farnfield on record concern Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.). Between 13 November 2020 and 13 August 2021, the trades on record add up to 5 filings.
Every open-market trade on record is a sale: 4 sales worth €90k. Other entries cover 1 option exercise. In 2021 alone, the filings show no purchases and 4 sales.
The record was last updated on 16 August 2021 with an open-market sale (€60k) in Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.). Filings reach the SEDI feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations